Estimation of invasive pneumococcal disease dynamics parameters and the impact of conjugate vaccination in Australia
Pneumococcal diseases, or infections from the etiological agent Streptococcus pneumoniae, have long been a major cause of morbidity andmortality worldwide. Recent advances in the development of vaccines for theseinfections have raised questions concerning their widespread and/or long-termuse. In thi...
Saved in:
Main Authors: | Karyn L. Sutton, H.T. Banks, Carlos Castillo-Chávez |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2007-12-01
|
Series: | Mathematical Biosciences and Engineering |
Subjects: | |
Online Access: | https://www.aimspress.com/article/doi/10.3934/mbe.2008.5.175 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015
by: Ting-An Yen, et al.
Published: (2025-02-01) -
Impact of invasive and noninvasive pneumococcal diseases on adult populations: risk factors and vaccination status
by: Hasip Kahraman, et al.
Published: (2025-02-01) -
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
by: Alane Izu, et al.
Published: (2025-12-01) -
Factors Affecting Influenza and Pneumococcal Vaccination Rates in Hemodialysis Patients: A Multicenter Study
by: Selen T, et al.
Published: (2025-01-01) -
Establishing a new human pneumococcal standard reference serum, MPRSS-01
by: Joseph M. Antonello, et al.
Published: (2025-01-01)